Ellen O'Connor Vos, Director at OptimizeRx Corp (OPRX), bought 28,000 shares at $0.77 ($22K) on 2017-02-06, disclosed to the SEC on 2017-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.77 | 1,000 | $770 | 3.5% |
| 2 | $0.73 | 1,000 | $730 | 3.4% |
| 3 | $0.76 | 1,000 | $760 | 3.5% |
| 4 | $0.75 | 2,000 | $2K | 6.9% |
| 5 | $0.70 | 2,000 | $1K | 6.4% |
| 6 | $0.77 | 1,000 |
| $770 |
| 3.5% |
| 7 | $0.75 | 1,000 | $750 | 3.4% |
| 8 | $0.71 | 1,000 | $710 | 3.3% |
| 9 | $0.70 | 1,000 | $700 | 3.2% |
| 10 | $0.85 | 1,000 | $850 | 3.9% |
| 11 | $0.81 | 1,000 | $810 | 3.7% |
| 12 | $0.81 | 2,000 | $2K | 7.4% |
| 13 | $0.85 | 1,000 | $850 | 3.9% |
| 14 | $0.82 | 2,000 | $2K | 7.5% |
| 15 | $0.81 | 1,000 | $810 | 3.7% |
| 16 | $0.81 | 1,000 | $810 | 3.7% |
| 17 | $0.80 | 1,000 | $800 | 3.7% |
| 18 | $0.81 | 2,000 | $2K | 7.4% |
| 19 | $0.81 | 1,000 | $810 | 3.7% |
| 20 | $0.81 | 1,000 | $810 | 3.7% |
| 21 | $0.74 | 2,000 | $1K | 6.8% |
| 22 | $0.75 | 1,000 | $750 | 3.4% |
| Total | $0.78 avg | 28,000 | $22K | 100% |
| Filing → |
| MODD | BUY | 2021-11-01 | $300K | — | Filing → |
| OPRX | BUY | 2020-04-01 | $9K | — | Filing → |
| OPRX | BUY | 2019-11-14 | $6K | — | Filing → |